Scope
Reference
C352808
Description
Project title: NHS National Framework for Transition products (Nilotinib and Ticagrelor) commencing 1st September 2025
Offer reference number: CM/TNS/24/5721
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Potential periods of call-offs under the framework agreement:
CM/TNS/24/5721/01 - Nilotinib and Ticagrelor
Lot 1 DCE/DNW/DNE: 01/09/2025 to 31/01/2027 (17 months)
Lot 2 DLN/DLS/DSW: 01/09/2025 to 31/01/2027 (17 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Please note that the contract had erroneously been advertised as an open framework at the tender stage and should have been advertised as a standalone framework.
Additional Unsuccessful supplier not listed due to technical error:
Torrent Pharma (UK) Ltd
Commercial tool
Establishes a framework
Framework
Maximum percentage fee charged to suppliers
0%
Framework operation description
Please refer to the ITO Documents for the Operation Description
Award method when using the framework
With competition
Contracting authorities that may use the framework
Establishing party only
Contract 1. NHS National Framework for Transition products (Nilotinib and Ticagrelor)
Suppliers (7)
- Accord-UK Ltd
- AstraZeneca
- Dr.Reddy's Laboratories (UK) Limited
- MSN Laboratories Europe Limited
- Novartis Pharmaceuticals UK Ltd
- Zentiva Pharma UK Ltd
- Zydus Pharmaceuticals UK Ltd
Contract value
- £22,097,000 excluding VAT
- £26,516,400 including VAT
Above the relevant threshold
Date signed
4 August 2025
Contract dates
- 1 September 2025 to 31 January 2027
- Possible extension to 31 January 2029
- 3 years, 5 months
Description of possible extension:
option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Signed contract documents
CONTRACT COPY - 03 Framework Agreement and Terms and Conditions - Contract Details Notice CM-TNS-24-5721.pdf
Other information
Applicable trade agreements
- Government Procurement Agreement (GPA)
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Open procedure
Suppliers
Accord-UK Ltd
- Companies House: 00079585
Whiddon Valley
Devon
EX32 8NS
United Kingdom
Region: UKK43 - Devon CC
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 1. NHS National Framework for Transition products (Nilotinib and Ticagrelor)
AstraZeneca
- Companies House: 03674842
2 Pancras Sq
London
N1C 4AG
United Kingdom
Email: roman.rojik@astrazeneca.com
Region: UKI31 - Camden and City of London
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 1. NHS National Framework for Transition products (Nilotinib and Ticagrelor)
Dr.Reddy's Laboratories (UK) Limited
- Companies House: 01729064
410 Cambridge Science Park Milton Road
Cambridge
CB4 0PE
United Kingdom
Email: drlukhospital@drreddys.com
Region: UKH12 - Cambridgeshire CC
Small or medium-sized enterprise (SME): Yes
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 1. NHS National Framework for Transition products (Nilotinib and Ticagrelor)
MSN Laboratories Europe Limited
- Companies House: 10185013
Invision House
Hitchin
SG4 0TY
United Kingdom
Email: jocelyn.ligas@msnlabs.com
Region: UKH23 - Hertfordshire
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 1. NHS National Framework for Transition products (Nilotinib and Ticagrelor)
Novartis Pharmaceuticals UK Ltd
- Companies House: 00119006
2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane,
London
W12 7FQ
United Kingdom
Region: UKI33 - Kensington & Chelsea and Hammersmith & Fulham
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 1. NHS National Framework for Transition products (Nilotinib and Ticagrelor)
Zentiva Pharma UK Ltd
- Companies House: 02158996
12 New Fetter Lane
London
EC4A 1JP
United Kingdom
Region: UKI31 - Camden and City of London
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 1. NHS National Framework for Transition products (Nilotinib and Ticagrelor)
Zydus Pharmaceuticals UK Ltd
- Companies House: 14646636
First Floor Templeback
Bristol
BS1 6FL
United Kingdom
Email: josh.ferguson@zydusuk.com
Region: UKK11 - Bristol, City of
Small or medium-sized enterprise (SME): Yes
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 1. NHS National Framework for Transition products (Nilotinib and Ticagrelor)
Contracting authority
NHS England
- Public Procurement Organisation Number: PDPT-3135-BWWY
Wellington House, 133-135 Waterloo Rd
London
SE1 8UG
United Kingdom
Email: katie.noonan@nhs.net
Website: https://www.england.nhs.uk/
Region: UKI45 - Lambeth
Organisation type: Public authority - central government